To explore the prognostic value of COL10A1 in the TCGA-BLCA database, patients were divided into high and low BLCA expression groups based on the optimal cutoff calculated via “survival” and “survminer” packages (Supplementary Figure 2A). This evidence concerns the gene COL10A1 and bladder transitional cell carcinoma.